Search Protocols under revision. Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapyHematologic NeoplasmsSolid TumorsProtocol groupPlasma cell neoplasmsSarcomasTransplantationDiseaseEwing SarcomaMultiple MyelomaStem Cell Transplantation, AutologousSubgroupICD10C40.-C41.-C90.-C90.0-Z94.80MeSHSarcoma, EwingTransplantation, AutologousSequenceEWING 2012 Arm A VIDEEWING 2012 Arm B VDC/IEChemotherapyChemo-substanceChemo-substanceChemo-substanceChemo-substanceNo. Substances RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanUrsodeoxycholic acidValaciclovirSupportive substanceBalanced Crystalloid SolutionBusulfanCiprofloxacinCotrimoxazoleDexamethasoneFosaprepitantGranisetronLevetiracetamMelphalanUrsodeoxycholic acidValaciclovirNo. Substances11Protocol classificationTherapy classificationcurrent standardIntensityHochdosis, bei autologer SZTTherapy indicationseveral possibleTherapy phaseautologous stem cell transplantationTherapy intentioncurativeRisksEmetogenicityEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorAnderton JDiseaseEwing Sarkom, ErstlinieOriginEuro Ewing 2012 protocolProtokolle in Überarbeitung 1 protocol foundBusulfan 0.8 / Melphalan 140, Autologous Stem Cell Transplantation (PID571 V1.2)
